Literature DB >> 29396655

A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit.

Boun Kim Tan1, Emmanuel Vivier2, Karim Ait Bouziad3, Jean-Ralph Zahar4,5, Christian Pommier2, Laurence Parmeland6, Caroline Pariset7, Pauline Misslin8, Catherine Haond9, Philippe Poirié10, Laura Temime3,11, Mounia N Hocine3,11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29396655     DOI： 10.1007/s00134-018-5079-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime.

Authors:  P Grohs; S Kernéis; B Sabatier; M Lavollay; E Carbonnelle; H Rostane; C Souty; G Meyer; L Gutmann; J L Mainardi
Journal:  J Antimicrob Chemother       Date:  2013-10-24       Impact factor: 5.790

Review 2.  Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Authors:  Matteo Bassetti; Garyphallia Poulakou; Etienne Ruppe; Emilio Bouza; Sebastian J Van Hal; Adrian Brink
Journal:  Intensive Care Med       Date:  2017-07-21       Impact factor: 17.440

3.  The influence of third-generation cephalosporins on the aerobic intestinal flora.

Authors:  J P Guggenbichler; J Kofler; F Allerberger
Journal:  Infection       Date:  1985       Impact factor: 3.553

4.  National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.

Authors:  Lucy McDonnell; David Armstrong; Mark Ashworth; Alexandru Dregan; Umer Malik; Patrick White
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790

5.  Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012.

Authors:  M Colomb-Cotinat; J Lacoste; C Brun-Buisson; V Jarlier; B Coignard; S Vaux
Journal:  Antimicrob Resist Infect Control       Date:  2016-12-12       Impact factor: 4.887
  5 in total
  3 in total

Review 1.  [S2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults : Focussed summary and supplementary information on antibiotic treatment of critically ill patients].

Authors:  A Brinkmann; A C Röhr; O R Frey; W A Krüger; T Brenner; D C Richter; K-F Bodmann; M Kresken; B Grabein
Journal:  Anaesthesist       Date:  2018-12       Impact factor: 1.041

Review 2.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

3.  A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment.

Authors:  Matthieu Grégoire; Florian Berteau; Ronan Bellouard; Quentin Lebastard; Philippe Aubert; Jacques Gonzales; François Javaudin; Anne Bessard; Pascale Bemer; Éric Batard; Didier Lepelletier; Michel Neunlist; Emmanuel Montassier; Éric Dailly
Journal:  Comput Struct Biotechnol J       Date:  2021-03-04       Impact factor: 7.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.